CB CAMBRYN BIOLOGICS

Serial Number 85695436
Registration 4305317
710

Registration Progress

Application Filed
Aug 4, 2012
Under Examination
Approved for Publication
Jan 1, 2013
Published for Opposition
Jan 1, 2013
Registered
Mar 19, 2013

Basic Information

Serial Number
85695436
Registration Number
4305317
Filing Date
August 4, 2012
Registration Date
March 19, 2013
Published for Opposition
January 1, 2013
Cancellation Date
September 29, 2023
Drawing Code
5000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Sep 29, 2023

Rights Holder

Cambryn Biologics, LLC

16
Address
600 Tallevast Rd.
Sarasota, FL 34243

Ownership History

Cambryn Biologics, LLC

Original Applicant
16
Sarasota, FL

Cambryn Biologics, LLC

Owner at Publication
16
Sarasota, FL

Cambryn Biologics, LLC

Original Registrant
16
Sarasota, FL

Legal Representation

Attorney
Sherry H. Flax

USPTO Deadlines

Next Renewal Deadline
2811 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2013-03-19)
Due Date
March 19, 2033
Grace Period Ends
September 19, 2033

Application History

25 events
Date Code Type Description
Sep 29, 2023 CAEX O CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Mar 19, 2022 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Nov 28, 2018 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 28, 2018 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Nov 28, 2018 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Nov 6, 2018 E815 I TEAS SECTION 8 & 15 RECEIVED
Mar 19, 2018 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 19, 2013 R.PR A REGISTERED-PRINCIPAL REGISTER
Jan 1, 2013 PUBO A PUBLISHED FOR OPPOSITION
Jan 1, 2013 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 12, 2012 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 27, 2012 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 26, 2012 ALIE A ASSIGNED TO LIE
Nov 7, 2012 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 6, 2012 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 5, 2012 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 5, 2012 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 1, 2012 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Nov 1, 2012 EPEN O COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Nov 1, 2012 GEAP F EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Nov 1, 2012 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Oct 30, 2012 DOCK D ASSIGNED TO EXAMINER
Aug 14, 2012 MPMK O NOTICE OF PSEUDO MARK MAILED
Aug 13, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2012 NWAP I NEW APPLICATION ENTERED

Additional Information

Design Mark
The mark consists of the stylized letters "CB" and the wording "CAMBRYN BIOLOGICS".
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
CB CAMBRYN BIOLOGICS

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOLOGICS"